查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1276859

螢光原位雜合反應(FISH)的全球市場:產業趨勢與預測(～2030年)

Global Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030
出版日期: | 出版商: Data Bridge Market Research | 英文 616 Pages | 商品交期: 請詢問到貨日

價格

全球螢光原位雜合反應(FISH)的市場規模在2023年～2030年的預測期間將記錄8.2％的年複合成長率。

由於對遺傳性疾病更高質量護理的需求不斷增加、個性化醫療的日益採用以及由於乳腺癌和乳腺癌患者數量的增加而擴使用 FISH 技術，螢光原位雜交 (FISH) 已成為全球趨勢。其他慢性病，是市場的主要增長動力。

本報告提供全球螢光原位雜合反應(FISH)市場相關調查分析，提供市場概要，各市場區隔·各地區的市場分析，競爭分析，企業簡介等系統性資訊。

目錄

第1章 簡介

第2章 市場明細

第3章 摘要整理

第4章 重要考察

  • 波特的五力分析
  • PESTEL分析
  • 產業考察
  • 結論

第5章 全球螢光原位雜合反應(FISH)市場:法律規範

第6章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第7章 全球螢光原位雜合反應(FISH)市場:各產品類型

  • 概要
  • 消耗品
  • 設備
  • 軟體

第8章 全球螢光原位雜合反應(FISH)市場:各技術

  • 概要
  • RNA
  • DNA
  • PNA
  • 其他

第9章 全球螢光原位雜合反應(FISH)市場:各用途

  • 概要
  • 癌症研究
  • 遺傳基因研究
  • 感染疾病
  • 個人化醫療
  • 其他

第10章 全球螢光原位雜合反應(FISH)市場:各使用目的

  • 概要
  • 研究
  • 臨床
  • 伴隨式診斷

第11章 全球螢光原位雜合反應(FISH)市場:各終端用戶

  • 概要
  • 診斷研究所
  • 醫院·診所
  • 製藥企業·生物科技企業
  • 學術研究機關
  • 委託研究機關
  • 其他

第12章 全球螢光原位雜合反應(FISH)市場:各流通管道

  • 概要
  • 零售
  • 線上銷售
  • 直接競標
  • 其他

第13章 全球螢光原位雜合反應(FISH)市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 瑞士
    • 土耳其
    • 比利時
    • 荷蘭
    • 丹麥
    • 瑞典
    • 波蘭
    • 挪威
    • 芬蘭
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
    • 新加坡
    • 泰國
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 澳洲
    • 紐西蘭
    • 越南
    • 台灣
    • 其他亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美
  • 中東·非洲
    • 南非
    • 沙烏地阿拉伯
    • 埃及
    • 阿拉伯聯合大公國
    • 科威特
    • 卡達
    • 阿曼
    • 巴林
    • 其他中東·非洲

第14章 全球螢光原位雜合反應(FISH):企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲

第15章 SWOT分析

第16章 企業簡介

  • MERCK KGAA
  • ABBOTT
  • AGILENT TECHNOLOGIES, INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • THERMO FISCHER SCIENTIFIC INC.
  • ABCAM PLC.
  • ABNOVA CORPORATION
  • BIO SB
  • BIOCARE MEDICAL, LLC
  • BIOCAT GMBH
  • BIODOT

The global Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 8.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Global Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar, Egypt, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the global Fluorescent in Situ Hybridization (FISH) market are:

Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine

Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases

Market Players

Some of the major market players operating in the global Fluorescent in Situ Hybridization (FISH) market are:

Abbott

Abcam plc.

Abnova Corporation

Agilent Technologies, Inc.

Bio SB

Biocare Medical, LLC

BioCat GmbH

BioDot

BioGenex

Bio-Techne

BIOZOL Diagnostics Vertrieb GmbH

Excilone

F.Hoffmann-La Roche Ltd

Genemed Biotechnologies, Inc.

Kaneka Eurogentec S.A.

Leica Biosystems Nussloch GmbH

Merck KGaA

MetaSystems

Sysmex Asia-Pacific Pte Ltd (a subsidiary of Sysmex Corporation)

Thermo Fischer Scientific Inc.

Zytomed Systems GmbH

TABLE OF CONTENTS

1 INTRODUCTION 68

  • 1.1 OBJECTIVES OF THE STUDY 68
  • 1.2 MARKET DEFINITION 68
  • 1.3 OVERVIEW 68
  • 1.4 CURRENCY AND PRICING 70
  • 1.5 LIMITATIONS 70
  • 1.6 MARKETS COVERED 71

2 MARKET SEGMENTATION 74

  • 2.1 MARKETS COVERED 74
  • 2.2 GEOGRAPHICAL SCOPE 75
  • 2.3 YEARS CONSIDERED FOR THE STUDY 76
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 77
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 80
  • 2.6 MULTIVARIATE MODELLING 81
  • 2.7 MARKET APPLICATION COVERAGE GRID 82
  • 2.8 PRODUCT LIFELINE CURVE 83
  • 2.9 DBMR MARKET POSITION GRID 84
  • 2.10 VENDOR SHARE ANALYSIS 86
  • 2.11 SECONDARY SOURCES 87
  • 2.12 ASSUMPTIONS 87

3 EXECUTIVE SUMMARY 88

4 PREMIUM INSIGHTS 91

  • 4.1 PORTER'S FIVE FORCES 94
  • 4.2 PESTEL ANALYSIS 95
  • 4.3 INDUSTRY INSIGHTS 96
  • 4.4 CONCLUSION 97

5 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: REGULATORY FRAMEWORK 98

6 MARKET OVERVIEW 100

  • 6.1 DRIVERS 102
    • 6.1.1 GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER 102
    • 6.1.2 INNOVATION AND ADVANCEMENTS IN FISH PRODUCTS 102
    • 6.1.3 HIGH FUNDING FOR RESEARCH ACTIVITIES 103
    • 6.1.4 RISING DEMAND AND USAGE OF FISH TECHNIQUES 103
  • 6.2 RESTRAINTS 104
    • 6.2.1 HIGH COST OF FISH TESTING 104
    • 6.2.2 LIMITED AVAILABILITY OF SKILLED PROFESSIONALS 104
  • 6.3 OPPORTUNITIES 105
    • 6.3.1 RISING PUBLIC AWARENESS ABOUT THE EARLY DETECTION OF GENETIC ABNORMALITIES 105
    • 6.3.2 RISE IN DEVELOPMENT OF SPECIFIC BIOMARKERS AND VARIOUS PROBES 105
  • 6.4 CHALLENGES 106
    • 6.4.1 STRINGENT GOVERNMENT REGULATIONS FOR THE APPROVAL OF FISH PROBES 106
    • 6.4.2 ETHICAL CONCERNS ASSOCIATED WITH FISH TECHNOLOGY 106

7 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE 107

  • 7.1 OVERVIEW 108
  • 7.2 CONSUMABLES 111
    • 7.2.1 FISH PROBE 111
      • 7.2.1.1 FISH PROBE, BY PROBE TYPE 112
        • 7.2.1.1.1 CHROMOSOME FISH PROBE 112
        • 7.2.1.1.2 SPLIT FISH PROBES 112
        • 7.2.1.1.3 TRANSLOCATION FISH PROBES 112
        • 7.2.1.1.4 SUBTELOMERE FISH PROBES 112
        • 7.2.1.1.5 PRENATAL FISH PROBES 112
        • 7.2.1.1.6 OTHERS PROBES 113
      • 7.2.1.2 FISH PROBE, BY TECHNOLOGY 113
        • 7.2.1.2.1 FLOW FLUORESCENT IN SITU HYBRIDIZATION 113
        • 7.2.1.2.2 C-ISH 113
        • 7.2.1.2.3 D-ISH 113
        • 7.2.1.2.4 Q- FLUORESCENT IN SITU HYBRIDIZATION 113
        • 7.2.1.2.5 OTHERS 113
      • 7.2.1.3 FISH PROBE, BY TYPE 114
        • 7.2.1.3.1 RNA 114
        • 7.2.1.3.1.1 MRNA 114
        • 7.2.1.3.1.2 MIRNA 114
        • 7.2.1.3.1.3 OTHERS 115
        • 7.2.1.3.2 DNA 115
    • 7.2.2 ACCESSORY KITS & REAGENTS 115
      • 7.2.2.1 KITS 115
      • 7.2.2.2 BUFFER 115
      • 7.2.2.3 DYES 115
      • 7.2.2.4 OTHERS 116
  • 7.3 INSTRUMENT 116
    • 7.3.1 STANDALONE 117
    • 7.3.2 PORTABLE 117
    • 7.3.3 HANDHELD 117
  • 7.4 SOFTWARE 117

8 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY 118

  • 8.1 OVERVIEW 119
  • 8.2 RNA FLUORESCENT IN SITU HYBRIDIZATION 122
  • 8.3 DNA FLUORESCENT IN SITU HYBRIDIZATION 123
  • 8.4 PNA FLUORESCENT IN SITU HYBRIDIZATION 124
  • 8.5 OTHERS 125

9 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION 126

  • 9.1 OVERVIEW 127
  • 9.2 CANCER RESEARCH 130
    • 9.2.1 CANCER RESEARCH, BY CANCER TYPE 131
      • 9.2.1.1 NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) 131
        • 9.2.1.1.1 BREAST CANCER 131
        • 9.2.1.1.2 LUNG CANCER 131
        • 9.2.1.1.3 MELANOMA 132
        • 9.2.1.1.4 PROSTRATE CANCER 132
        • 9.2.1.1.5 OVARIAN CANCER 132
        • 9.2.1.1.6 OTHERS 132
      • 9.2.1.2 HEMATOPOETIC MALIGNANCIES 132
        • 9.2.1.2.1 LEUKEMIA 132
        • 9.2.1.2.2 MULTIPLE MYELOMA 133
        • 9.2.1.2.3 MYELODYSPLASTIC SYNDROMES (MDS) 133
    • 9.2.2 CANCER RESEARCH, BY PRODUCT 133
      • 9.2.2.1 CONSUMABLES 133
      • 9.2.2.2 INSTRUMENTS 133
      • 9.2.2.3 SOFTWARE 133
  • 9.3 GENETIC RESEARCH 134
    • 9.3.1 CYTOGENETICS 135
    • 9.3.2 CHROMOSOMAL ABNORMALITIES 135
    • 9.3.3 OTHERS 135
  • 9.4 INFECTIOUS DISEASE 135
    • 9.4.1 CONSUMABLES 136
    • 9.4.2 INSTRUMENTS 136
    • 9.4.3 SOFTWARE 136
  • 9.5 PERSONALIZED MEDICINE 136
  • 9.6 OTHERS 137

10 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE 138

  • 10.1 OVERVIEW 139
  • 10.2 RESEARCH 142
    • 10.2.1 INSTRUMENTS 142
    • 10.2.2 CONSUMABLES 143
    • 10.2.3 SOFTWARE 143
  • 10.3 CLINICAL 143
    • 10.3.1 CONSUMABLES 144
    • 10.3.2 INSTRUMENT 144
    • 10.3.3 SOFTWARE 144
  • 10.4 COMPANION DIAGNOSTIC 144
    • 10.4.1 CONSUMABLES 145
    • 10.4.2 INSTRUMENT 145
    • 10.4.3 SOFTWARE 145

11 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER 146

  • 11.1 OVERVIEW 147
  • 11.2 DIAGNOSTIC LABORATORIES 150
  • 11.3 HOSPITALS & CLINICS 150
  • 11.4 PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES 151
  • 11.5 ACADEMIC & RESEARCH INSTITUTES 152
  • 11.6 CONTRACT RESEARCH ORGANIZATIONS 152
  • 11.7 OTHERS 153

12 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL 154

  • 12.1 OVERVIEW 155
  • 12.2 RETAIL SALES 158
  • 12.3 ONLINE SALES 158
  • 12.4 DIRECT TENDER 159
  • 12.5 OTHERS 160

13 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION 161

  • 13.1 OVERVIEW 162
  • 13.2 NORTH AMERICA 167
    • 13.2.1 U.S. 180
    • 13.2.2 CANADA 188
    • 13.2.3 MEXICO 196
  • 13.3 EUROPE 204
    • 13.3.1 GERMANY 218
    • 13.3.2 U.K. 226
    • 13.3.3 ITALY 234
    • 13.3.4 FRANCE 242
    • 13.3.5 SPAIN 250
    • 13.3.6 RUSSIA 258
    • 13.3.7 SWITZERLAND 266
    • 13.3.8 TURKEY 274
    • 13.3.9 BELGIUM 282
    • 13.3.10 NETHERLANDS 290
    • 13.3.11 DENMARK 298
    • 13.3.12 SWEDEN 306
    • 13.3.13 POLAND 314
    • 13.3.14 NORWAY 322
    • 13.3.15 FINLAND 330
    • 13.3.16 REST OF EUROPE 338
  • 13.4 ASIA-PACIFIC 339
    • 13.4.1 JAPAN 353
    • 13.4.2 CHINA 361
    • 13.4.3 SOUTH KOREA 369
    • 13.4.4 INDIA 377
    • 13.4.5 SINGAPORE 385
    • 13.4.6 THAILAND 393
    • 13.4.7 INDONESIA 402
    • 13.4.8 MALAYSIA 410
    • 13.4.9 PHILIPPINES 418
    • 13.4.10 AUSTRALIA 426
    • 13.4.11 NEW ZEALAND 434
    • 13.4.12 VIETNAM 442
    • 13.4.13 TAIWAN 450
    • 13.4.14 REST OF ASIA-PACIFIC 458
  • 13.5 SOUTH AMERICA 459
    • 13.5.1 BRAZIL 471
    • 13.5.2 ARGENTINA 479
    • 13.5.3 REST OF SOUTH AMERICA 487
  • 13.6 MIDDLE EAST AND AFRICA 488
    • 13.6.1 SOUTH AFRICA 502
    • 13.6.2 SAUDI ARABIA 512
    • 13.6.3 EGYPT 520
    • 13.6.4 UAE 529
    • 13.6.5 KUWAIT 537
    • 13.6.6 QATAR 546
    • 13.6.7 OMAN 554
    • 13.6.8 BAHRAIN 563
    • 13.6.9 REST OF MIDDLE EAST AND AFRICA 571

14 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, COMPANY LANDSCAPE 572

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 572
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 573
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 574
  • 14.4 COMPANY SHARE ANALYSIS: EUROPE 575

15 SWOT ANALYSIS 576

16 COMPANY PROFILE 577

  • 16.1 MERCK KGAA 577
    • 16.1.1 COMPANY SNAPSHOT 577
    • 16.1.2 REVENUE ANALYSIS 577
    • 16.1.3 COMPANY SHARE ANALYSIS 578
    • 16.1.4 PRODUCT PORTFOLIO 578
    • 16.1.5 RECENT DEVELOPMENT 578
  • 16.2 ABBOTT 579
    • 16.2.1 COMPANY SNAPSHOT 579
    • 16.2.2 REVENUE ANALYSIS 579
    • 16.2.3 COMPANY SHARE ANALYSIS 580
    • 16.2.4 PRODUCT PORTFOLIO 580
    • 16.2.5 RECENT DEVELOPMENT 581
  • 16.3 AGILENT TECHNOLOGIES, INC. 582
    • 16.3.1 COMPANY SNAPSHOT 582
    • 16.3.2 REVENUE ANALYSIS 582
    • 16.3.3 COMPANY SHARE ANALYSIS 583
    • 16.3.4 PRODUCT PORTFOLIO 583
    • 16.3.5 RECENT DEVELOPMENT 583
  • 16.4 F. HOFFMANN-LA ROCHE LTD. 584
    • 16.4.1 COMPANY SNAPSHOT 584
    • 16.4.2 REVENUE ANALYSIS 584
    • 16.4.3 COMPANY SHARE ANALYSIS 585
    • 16.4.4 PRODUCT PORTFOLIO 585
    • 16.4.5 RECENT DEVELOPMENT 585
  • 16.5 THERMO FISCHER SCIENTIFIC INC. 586
    • 16.5.1 COMPANY SNAPSHOT 586
    • 16.5.2 REVENUE ANALYSIS 586
    • 16.5.3 COMPANY SHARE ANALYSIS 587
    • 16.5.4 PRODUCT PORTFOLIO 587
    • 16.5.5 RECENT DEVELOPMENT 588
  • 16.6 ABCAM PLC. 589
    • 16.6.1 COMPANY SNAPSHOT 589
    • 16.6.2 REVENUE ANALYSIS 589
    • 16.6.3 COMPANY SHARE ANALYSIS 590
    • 16.6.4 PRODUCT PORTFOLIO 590
    • 16.6.5 RECENT DEVELOPMENTS 590
  • 16.7 ABNOVA CORPORATION 592
    • 16.7.1 COMPANY SNAPSHOT 592
    • 16.7.2 PRODUCT PORTFOLIO 592
    • 16.7.3 RECENT DEVELOPMENT 592
  • 16.8 BIO SB 593
    • 16.8.1 COMPANY SNAPSHOT 593
    • 16.8.2 PRODUCT PORTFOLIO 593
    • 16.8.3 RECENT DEVELOPMENT 593
  • 16.9 BIOCARE MEDICAL, LLC 594
    • 16.9.1 COMPANY SNAPSHOT 594
    • 16.9.2 PRODUCT PORTFOLIO 594
    • 16.9.3 RECENT DEVELOPMENT 595
  • 16.10 BIOCAT GMBH 596
    • 16.10.1 COMPANY SNAPSHOT 596
    • 16.10.2 PRODUCT PORTFOLIO 596
    • 16.10.3 RECENT DEVELOPMENT 597
  • 16.11 BIODOT 598
    • 16.11.1 COMPANY SNAPSHOT 598
    • 16.11.2 PRODUCT PORTFOLIO 598
    • 16.11.3 RECENT DEVELOPMENT 598
  • 16.12 BIOGENEX 599
    • 16.12.1 COMPANY SNAPSHOT 599
    • 16.12.2 PRODUCT PORTFOLIO 599
    • 16.12.3 RECENT DEVELOPMENT 599
  • 16.13 BIO-TECHNE 600
    • 16.13.1 COMPANY SNAPSHOT 600
    • 16.13.2 REVENUE ANALYSIS 600
    • 16.13.3 COMPANY SHARE ANALYSIS 601
    • 16.13.4 PRODUCT PORTFOLIO 601
    • 16.13.5 RECENT DEVELOPMENT 601
  • 16.14 BIOZOL DIAGNOSTICS VERTRIEB GMBH 602
    • 16.14.1 COMPANY SNAPSHOT 602
    • 16.14.2 PRODUCT PORTFOLIO 602
    • 16.14.3 RECENT DEVELOPMENT 603
  • 16.15 EXCILONE 604
    • 16.15.1 COMPANY SNAPSHOT 604
    • 16.15.2 PRODUCT PORTFOLIO 604
    • 16.15.3 RECENT DEVELOPMENT 604
  • 16.16 GENEMED BIOTECHNOLOGIES, INC. 605
    • 16.16.1 COMPANY SNAPSHOT 605
    • 16.16.2 PRODUCT PORTFOLIO 605
    • 16.16.3 RECENT DEVELOPMENT 605
  • 16.17 KANEKA EUROGENTEC S.A. 606
    • 16.17.1 COMPANY SNAPSHOT 606
    • 16.17.2 PRODUCT PORTFOLIO 606
    • 16.17.3 RECENT DEVELOPMENT 606
  • 16.18 LEICA BIOSYSTEMS NUSSLOCH GMBH 607
    • 16.18.1 COMPANY SNAPSHOT 607
    • 16.18.2 PRODUCT PORTFOLIO 607
    • 16.18.3 RECENT DEVELOPMENT 607
  • 16.19 METASYSTEMS 608
    • 16.19.1 COMPANY SNAPSHOT 608
    • 16.19.2 PRODUCT PORTFOLIO 608
    • 16.19.3 RECENT DEVELOPMENT 608
  • 16.20 SYSMEX ASIA PACIFIC PTE LTD (A SUBSIDIARY OF SYSMEX CORPORATION) 609
    • 16.20.1 COMPANY SNAPSHOT 609
    • 16.20.2 REVENUE ANALYSIS 609
    • 16.20.3 PRODUCT PORTFOLIO 610
    • 16.20.4 RECENT DEVELOPMENT 610
  • 16.21 ZYTOMED SYSTEMS GMBH 611
    • 16.21.1 COMPANY SNAPSHOT 611
    • 16.21.2 PRODUCT PORTFOLIO 611
    • 16.21.3 RECENT DEVELOPMENT 611

17 QUESTIONNAIRE 612

18 RELATED REPORTS 616

LIST OF TABLES

  • TABLE 1 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
  • TABLE 2 GLOBAL CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 3 GLOBAL CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
  • TABLE 4 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 5 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 113
  • TABLE 6 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 7 GLOBAL RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 8 GLOBAL ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
  • TABLE 9 GLOBAL INSTRUMENT IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 10 GLOBAL INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
  • TABLE 11 GLOBAL SOFTWARE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 12 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 121
  • TABLE 13 GLOBAL RNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 14 GLOBAL DNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 123
  • TABLE 15 GLOBAL PNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 124
  • TABLE 16 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 17 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
  • TABLE 18 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 130
  • TABLE 19 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 20 GLOBAL NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
  • TABLE 21 GLOBAL HEMATOPOETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
  • TABLE 22 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 23 GLOBAL GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 134
  • TABLE 24 GLOBAL GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
  • TABLE 25 GLOBAL INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 26 GLOBAL INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 27 GLOBAL PERSONALIZED MEDICINE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 137
  • TABLE 28 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 137
  • TABLE 29 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 141
  • TABLE 30 GLOBAL RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 142
  • TABLE 31 GLOBAL RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 142
  • TABLE 32 GLOBAL CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 143
  • TABLE 33 GLOBAL CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 144
  • TABLE 34 GLOBAL COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 145
  • TABLE 35 GLOBAL COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 145
  • TABLE 36 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 149
  • TABLE 37 GLOBAL DIAGNOSTIC LABORATORIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 150
  • TABLE 38 GLOBAL HOSPITALS & CLINICS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 151
  • TABLE 39 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 151
  • TABLE 40 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 152
  • TABLE 41 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 153
  • TABLE 42 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 153
  • TABLE 43 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 157
  • TABLE 44 GLOBAL RETAIL SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 158
  • TABLE 45 GLOBAL ONLINE SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 159
  • TABLE 46 GLOBAL DIRECT TENDER IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 159
  • TABLE 47 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 160
  • TABLE 48 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 166
  • TABLE 49 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 171
  • TABLE 50 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 51 NORTH AMERICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 52 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 53 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 172
  • TABLE 54 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 55 NORTH AMERICA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 56 NORTH AMERICA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 57 NORTH AMERICA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 58 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 174
  • TABLE 59 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 175
  • TABLE 60 NORTH AMERICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 61 NORTH AMERICA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
  • TABLE 62 NORTH AMERICA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
  • TABLE 63 NORTH AMERICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
  • TABLE 64 NORTH AMERICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
  • TABLE 65 NORTH AMERICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
  • TABLE 66 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
  • TABLE 67 NORTH AMERICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
  • TABLE 68 NORTH AMERICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
  • TABLE 69 NORTH AMERICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 179
  • TABLE 70 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 179
  • TABLE 71 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 179
  • TABLE 72 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 73 U.S. CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 74 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 75 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 181
  • TABLE 76 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 77 U.S. RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 78 U.S. ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 79 U.S. INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 80 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 183
  • TABLE 81 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
  • TABLE 82 U.S. CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 83 U.S. NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 84 U.S. HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 85 U.S. CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 185
  • TABLE 86 U.S. GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 185
  • TABLE 87 U.S. INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 185
  • TABLE 88 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
  • TABLE 89 U.S. RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
  • TABLE 90 U.S. CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
  • TABLE 91 U.S. COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 187
  • TABLE 92 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 187
  • TABLE 93 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 187
  • TABLE 94 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 95 CANADA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 96 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 97 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 189
  • TABLE 98 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 99 CANADA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 100 CANADA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 101 CANADA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 102 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 191
  • TABLE 103 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 191
  • TABLE 104 CANADA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 105 CANADA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
  • TABLE 106 CANADA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
  • TABLE 107 CANADA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 193
  • TABLE 108 CANADA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 193
  • TABLE 109 CANADA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 193
  • TABLE 110 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
  • TABLE 111 CANADA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
  • TABLE 112 CANADA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
  • TABLE 113 CANADA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 195
  • TABLE 114 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 195
  • TABLE 115 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 195
  • TABLE 116 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 117 MEXICO CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 118 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 119 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 197
  • TABLE 120 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 121 MEXICO RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 122 MEXICO ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 123 MEXICO INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 124 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 199
  • TABLE 125 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 199
  • TABLE 126 MEXICO CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 127 MEXICO NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 200
  • TABLE 128 MEXICO HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 200
  • TABLE 129 MEXICO CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 201
  • TABLE 130 MEXICO GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 201
  • TABLE 131 MEXICO INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 201
  • TABLE 132 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
  • TABLE 133 MEXICO RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
  • TABLE 134 MEXICO CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
  • TABLE 135 MEXICO COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 203
  • TABLE 136 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 203
  • TABLE 137 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 203
  • TABLE 138 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 209
  • TABLE 139 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210
  • TABLE 140 EUROPE CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210

LIST OF FIGURES

  • FIGURE 1 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 74
  • FIGURE 2 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DATA TRIANGULATION 77
  • FIGURE 3 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DROC ANALYSIS 78
  • FIGURE 4 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 79
  • FIGURE 5 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY RESEARCH ANALYSIS 79
  • FIGURE 6 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: INTERVIEW DEMOGRAPHICS 80
  • FIGURE 7 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: MARKET APPLICATION COVERAGE GRID 82
  • FIGURE 8 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DBMR MARKET POSITION GRID 84
  • FIGURE 9 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: VENDOR SHARE ANALYSIS 86
  • FIGURE 10 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 90
  • FIGURE 11 THE GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER AND HIGH FUNDING FOR RESEARCH ACTIVITIES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET FROM 2023 TO 2030 91
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET IN 2023 AND 2030 91
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 92
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 93
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET 101
  • FIGURE 16 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2022 108
  • FIGURE 17 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 109
  • FIGURE 18 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 109
  • FIGURE 19 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 110
  • FIGURE 20 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2022 119
  • FIGURE 21 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 120
  • FIGURE 22 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, CAGR (2023-2030) 120
  • FIGURE 23 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, LIFELINE CURVE 121
  • FIGURE 24 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2022 127
  • FIGURE 25 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 128
  • FIGURE 26 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, CAGR (2023-2030) 128
  • FIGURE 27 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, LIFELINE CURVE 129
  • FIGURE 28 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2022 139
  • FIGURE 29 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2023-2030 (USD MILLION) 140
  • FIGURE 30 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, CAGR (2023-2030) 140
  • FIGURE 31 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, LIFELINE CURVE 141
  • FIGURE 32 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2022 147
  • FIGURE 33 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2023-2030 (USD MILLION) 148
  • FIGURE 34 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, CAGR (2023-2030) 148
  • FIGURE 35 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, LIFELINE CURVE 149
  • FIGURE 36 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2022 155
  • FIGURE 37 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 156
  • FIGURE 38 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 156
  • FIGURE 39 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 157
  • FIGURE 40 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 163
  • FIGURE 41 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2022) 164
  • FIGURE 42 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2023 & 2030) 164
  • FIGURE 43 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2022 & 2030) 165
  • FIGURE 44 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE (2023 & 2030) 165
  • FIGURE 45 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 168
  • FIGURE 46 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 169
  • FIGURE 47 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 169
  • FIGURE 48 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 170
  • FIGURE 49 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 170
  • FIGURE 50 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 205
  • FIGURE 51 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 206
  • FIGURE 52 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 206
  • FIGURE 53 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 207
  • FIGURE 54 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 208
  • FIGURE 55 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 340
  • FIGURE 56 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 341
  • FIGURE 57 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 341
  • FIGURE 58 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 342
  • FIGURE 59 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 343
  • FIGURE 60 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 460
  • FIGURE 61 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 461
  • FIGURE 62 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 461
  • FIGURE 63 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 462
  • FIGURE 64 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 462
  • FIGURE 65 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 489
  • FIGURE 66 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 490
  • FIGURE 67 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 490
  • FIGURE 68 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 491
  • FIGURE 69 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 492
  • FIGURE 70 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 572
  • FIGURE 71 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 573
  • FIGURE 72 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 574
  • FIGURE 73 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 575